• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND IN.PACT AV ACCESS; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLAS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND IN.PACT AV ACCESS; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLAS Back to Search Results
Model Number IAV06006008P
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Stenosis (2263)
Date of Event 12/15/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
During the index procedure one in.Pact av access balloon was used to treat the in cannulation zone of the left arm.During a second procedure, the anastomosis of the left arm was treated using a non mdt balloon.During a third procedure, the central vein and the anastomosis of the left arm were treated with one in.Pact av access balloon and one non mdt balloon each.During a fourth procedure, the anastomosis of the left arm was treated using two non mdt balloons.During a fifth procedure the in cannulation zone and central vein of the left arm were treated with one in.Pact admiral balloon and four non mdt balloons.Approximately 11 months post the index procedure, 8 months post the second procedure, 5 months post the third procedure, 4 months post the fourth procedure and 1 month post the fifth procedure, the patient suffered from restenosis of the cannulation zone of the brachio-basilic avf.The patient was treated with medication and a percutaneous intervention with dcb, plain balloon, high pressure balloon and cutting balloon resulting in a final residual stenosis of 15%.During this percutaneous intervention 6 non mdt balloons were used to treat the in cannulation zone of the left arm.The patient recovered.The ae was assessed as possibly related to an underlying condition or disease.
 
Additional Manufacturer Narrative
Additional information: the sponsor and the cec assessed, the event as related to the device model#: iav06006008p, lot#: 0009835623.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank, because the information is currently, unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IN.PACT AV ACCESS
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLAS
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key16136159
Report Number9612164-2023-00125
Device Sequence Number6669481
Product Code ONU
UDI-Device Identifier00763000232573
UDI-Public00763000232573
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
P190008
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/20/2022
Device Model NumberIAV06006008P
Device Catalogue NumberIAV06006008P
Device Lot Number0009835623
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/16/2022
Supplement Date Received by Manufacturer03/09/2023
Initial Report FDA Received Date01/11/2023
Supplement Report FDA Received Date03/28/2023
Date Device Manufactured07/21/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age79 YR
Patient SexMale
Patient Weight63 KG
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-